Introduction
Hepatocellular carcinoma (HCC) is the most common type of liver cancer and a leading cause of cancer-related death worldwide (nearly 600,000 deaths annually) (1) .
HCC is recorded with the worst prognosis according to a population-based cancer registry data in China that the age-standardized 5-year relative survival rates for males and females are 10.2% and 10.3%, respectively (2) . The high lethality of HCC is partly due to its high recurrence rate based on the concept of "field cancerization" (3) . Acyclic retinoid (ACR), a synthetic vitamin A-like compound, was originally developed from a view of nutritional supplementation to improve the vitamin A content in HCC patients (4) . Clinical trials revealed that ACR could significantly inhibit the recurrence of HCC after the remove of primary tumors (4, 5) . It is hypothesized that this recurrence preventive effect is associated with clonal deletion (6) through targeted elimination of cancer stem/progenitor cells, such as oval-like cells (7, 8) . However, the detailed mechanisms underlying the prevention of hepatic tumorigenesis by ACR still need further investigation.
Metabolic alterations of cancer cells such as aerobic glycolysis are essential to generate energy and nutrients required for cancer cell processes (9). It is also believed Author Manuscript Published OnlineFirst on January 7, 2016; DOI: 10.1158/1940-6207.CAPR- molecules in proliferating cancer cells (10). For example, serum metabolic profiling study demonstrated that the content of arachidonic acid (AA), a polyunsaturated fatty acid present in the phospholipids of cell membranes, was significantly elevated in HCC patients compared to the healthy controls (~91.8-fold) (11). In addition, metabolic reprogramming has been revealed to be regulated by proto-oncogenes and tumor suppressor genes, suggesting its primary function in tumorigenesis (12) (13) (14) . Although viral hepatitis is the major causate of HCC, there is growing recognition of the importance of metabolic syndrome such as obesity for the development of HCC (15) .
Dietary or genetic obesity can induce alteration of gut microbial metabolites such as increasing the levels of deoxycholic acid (DHA), which leads to chronic liver injury and facilitates HCC development (16) . Interestingly, antibiotics treatments inhibiting DHA synthesis can prevent obesity-induced HCC development, suggesting abnormal metabolism of cancer cells is a potential therapeutic target for the systemic treatment and prevention of HCC (16, 17) .
Our group and others have observed that ACR may suppress cell growth or inhibit hepatitis C virus replication by altering energy production and lipid metabolism in HCC cell lines (18, 19) . However, in vitro study in malignant cells provides limited information to understand the mechanism of tumorigenesis. We reported that ACR 
Materials and Methods

Chemicals
ACR (NIK-333) was supplied by Kowa Co. Ltd. All-trans retinoic acid (atRA), DEN, and AA were purchased from Sigma-Aldrich.
Animal experiment
All experiment was performed in accordance with protocols approved by the Institutional Committee of Animal Experiment of Gifu University and RIKEN.
Four-week-old male db/db mice were obtained from Japan SLC, Inc. and housed under constant temperature (22°C ± 1°C), with free access to food and water, 12 h light and 12 h dark cycles and were fed laboratory pellets. Detailed experimental procedure was described previously (20) . Briefly, mice were divided into four groups (n = 6, respectively). Three groups were given tap water containing 40 ppm of DEN for the first two weeks and then fed with basal diet alone (DEN group) and basal diet containing 0.03% ACR (DEN-0.03ACR group) or 0.06% ACR (DEN-0.06ACR group) till the end of experiment. The method for DEN treatment used in this study has been proved to be sufficient to develop liver neoplasms in db/db mice (20, 22, 23 (0.06ACR group) was used as the negative control for changes during DEN-initiated liver tumorigenesis (Fig. 1A) . After sacrifice by CO 2 asphyxiation, liver tissues containing precancerous lesion but not cancer (approximately 60 mg/mouse) were isolated and stored at −80°C until further metabolic analyses. For histopathologic examination, 4-μm thick sections of formalin-fixed, paraffin-embedded livers were stained routinely with hematoxylin and eosin (H&E).
CE-TOFMS measurement
Frozen liver tissues were immersed into 50% acetonitrile solution containing internal standards in crushing tubes and centrifuged (2,300g, 4°C, 5 min) using a desk-model crusher BMS-M10N21 (BMS Co., Ltd.). After that, upper layer was centrifugally filtered (9,100g, 4°C, 120 min) using an UltrafreeMC-PLHCC 5-kDa cutoff filter (Human metabolome technologies Inc.). The filtrates were dried and resuspended in 50 μL of Milli-Q water for CE-TOFMS analysis using an Agilent CE-TOFMS system (Agilent Technologies) as previously described (21, 24) .
LC-TOFMS measurement
Frozen liver tissues were immersed into acetonitrile solution with 1% formic acid containing internal standards in crushing tubes and centrifuged (1,500 rpm, 4°C, 120 s) for 3 times using a desk-model crusher BMS-M10N21 (BMS Co., Ltd.) following another centrifugation (1,500 rpm, 4°C, 120 s) after adding 167 μL of Milli-Q water.
After that, supernatant was collected by centrifugation (5,000 g, 4°C, 5 min).
Meanwhile, the flow-through was mixed with 500 μL of acetonitrile solution with 1% formic acid and 167 μL of Milli-Q water and supernatant was collected again by centrifugation. The supernatants were then mixed and centrifugally filtered (9,100 g, 4°C, 120 min) using a Pall Nanosep 3K Omega filters (Pall Corp.). The filtrate was dried and resuspended in 100 μL of isopropanol/Milli-Q water solution (1:1) for LC-TOFMS analysis using an Agilent 1200 series RRLC system SL equipped with an Agilent LC/MSD TOF system (Agilent Technologies).
Metabolites identification and quantification
Raw data obtained were analyzed with KEIO MasterHands software version 2.13 as previously described (25) . Quantification of the major metabolites was performed as previously described (18, 25) . 
Microarray analysis
Total RNA was isolated from JHH7 cells before (0h) and after treatment with 1 μM atRA or 10 μM ACR for 1h and 4h using a RNeasy Kit (Qiagen). The amount and purity of the isolated RNA were evaluated using a NanoDrop spectrophotometer (NanoDrop products). Then, oligonucleotide microarray experiment was performed using Affymetrix HG-U133 Plus 2.0 Array (Affymetrix). The arrays were scanned using a GenePix 4000B microarray scanner (Axon Instruments). Data normalization and analysis were performed with GeneSpring GX13.0 (Agilent Technologies) as previously described (27) . All data are MIAME compliant, and the raw data were deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo, accession no. GSE71856).
Cancer Research. 
ELSIA
Cells were seeded in 10 cm dishes and allowed to grow to confluency. Cells were treated with 15 μM ACR in FBS free DMEM for 24 h. The cell lysates were isolated and the contents of AA was measured using an ELISA kit (CEB098Ge, Cloud-Clone Corp.) according to the manufacturer's protocol.
Network generation and pathway analysis
MetaboAnalyst software (http://www.metaboanalyst.ca) was used to identify metabolites with significantly different levels across experimental conditions and apply the enrichment analysis of associated metabolic pathways (28) . The Ingenuity Pathways Analysis (IPA) program (Ingenuity Systems) was used to identify networks and canonical pathways associated with differentially expressed genes following ACR treatment as previously described (27) .
Statistical and multivariate analysis
The statistical significance of differences between values was assessed using analysis of variance (ANOVA) with post-hoc Tukey HSD test or two-tailed Student's t-test. Table S1 ) and 102 lipophilic metabolites (Supplementary Table S2 ) were detected using CE-TOFMS and LC-TOFMS, respectively. Metabolomics comparison using PCA analysis on CE-TOFMS data (Fig. 1C) , LC-TOFMS data (Fig. 1D ) and the combined data ( 
metabolomics data of our mouse DEN-initiated HCC model (Supplementary Fig. S2 ).
Although no significance was observed, the ratio of creatine/betaine tended to increase in the DEN group.
Statistics analysis of significantly changed metabolites
Heatmap analysis of all detected metabolites by CE/LC-TOFMS also revealed strong and reproducible ACR/DEN-induced changes of liver metabolic profiles in mouse DEN-induced hepatic tumorigenesis model under differential experimental conditions (Fig. 3A) . ANOVA analysis with post-hoc Tukey HSD test identified a total of 61 metabolites were significantly changed across differential chemical treatments with the threshold that P-values less than 0.05 (Fig. 3B) . The top five of the most significantly changed metabolites were 1H-imidazole-4-propionic acid, cis-4,7,10,13,16,19-docosahexaenoic acid, arachidonic acid, phenylalanine (Phe), and cis-8,11,14-eicosatrienoic acid (Fig. 3C) . With more details, 88 metabolites were significantly changed in the DEN alone treated mice by comparing with the control mice treated with 0.06% ACR alone without DEN treatment (DEN vs 0.06ACR).
Meanwhile, 68 and 79 metabolites were significantly differential in mice treated with DEN combined with 0.03% and 0.06% ACR, respectively, by comparing with the mice (Fig. 3D) .
Biological process underlying preventive effect of ACR on hepatic tumorigenesis
Top metabolic pathways associated with metabolites significantly changed between DEN and 0.06ACR groups (Fig. 4A) , DEN-0.03ACR and DEN groups (Fig. 4B) , and DEN-0.06ACR and DEN groups (Fig. 4C) were identified using functional enrichment analyses in MetaboAnalyst software. Of interest, the top 2 metabolic pathways "Protein biosynthesis" and "Alpha linolenic acid and linoleic acid metabolism" were common in all the comparisons. Quantification results of the metabolites significantly inhibited by ACR treatment involved in the "Protein biosynthesis" and "Alpha linolenic acid and linoleic acid metabolism" were summarized in Figs. 5A and B, respectively. In contrast, no significant changes of metabolites involved in glucose metabolism such as glucose, glucose-6-phosphate and lactic acid were observed (Fig. 5C) . Furthermore, we investigated the effect of ACR on AA-induced cell growth of human HCC cells JHH7.
ACR inhibited the contents of AA in JHH7 cells (Supplementary Fig. S3 ) and Fig. S4 ).
Gene expression profiles of HCC cells in response to ACR
Hierarchical clustering with Ward's method of 44,907 genes detected by microarray analysis demonstrated diverse expression changes in HCC cells treated with ACR for 4h (Fig. 6A) . A total of 973 differentially expressed genes in response to ACR by comparing with atRA for 4h treatments were identified with a fold change more than 2.
Then, network analysis was performed on the altered gene expression profiles using IPA platform. The biological functions of the top IPA-generated networks were summarized in Fig. 6B . The most highly populated networks were associated with the regulation of cell cycle and DNA replication, as ACR is well known to induce apoptosis and suppress cell proliferation in HCC cells (31) . In addition, networks related to amino acid metabolism, protein synthesis and lipid metabolism were also observed. For example, the biological network entitled "Lipid Metabolism, Small Molecular Biochemistry, Vitamin and Mineral Metabolism" was highlighted in Fig. 6C . This network contains genes that play critical roles in controlling the development of tissues and organs such as the nuclear orphan receptor NR2F2. Then, the inhibitory effect of ACR on NR2F2 expressions was validated using real-time PCR (Fig. 6D) .
Finally, to mine the connection between the metabolic and genetic actions of ACR observed in this study, a NR2F2-dependent regulatory network was generated by knowledge based pathway analysis in IPA platform (Fig. 7) . A potential mechanism is that NR2F2 may bind to retinoid X retinoid (RXR), which is known as a molecular 
Discussion
There are raised efforts to target cancer metabolism as a potential anticancer strategy (17) . However, these therapies have been partly elusive due to the poor understanding of metabolic phenotypes in the tissue-specific tumorigenic process. One major finding of our study was that alterations in lipid metabolism but not glucose metabolism were observed in DEN-induced hepatic tumorigenesis. ACR can significantly inhibit the DEN-induced acceleration of lipogenesis, suggesting lipogenic pathway as potential cancer targets (Fig. 4) . Cancer metabolism has been long equated as aerobic glycolysis (known as "Warburg effect") (34), which is mainly based on the hypothesis of mitochondrial defects in cancer cells. However, this hypothesis is challenged by recent studies that most tumor mitochondria are not defective in their ability to carry out oxidative phosphorylation (12). Our previous in vitro study also raised questions regarding this issue that no significant difference in the content of lactic acid was observed between HCC cells, JHH7 and normal hepatic cells. In addition, increased gene expression of pyruvate dehydrogenase kinase 4 (PDK4), which attenuates the flux of glycolytic carbon into mitochondrial oxidation, was found to be involved in the growth suppression action of ACR in JHH7 cells (18) . As the JHH7 cells exhibiting highly enhanced liver differentiation functions and stem cell-like features (35) In this study, linoleic acid metabolism was identified as the mostly populated metabolic target of ACR (Fig. 3) . Decreases in linoleic acid metabolites such as AA have been suggested as a potential mechanism from mammary cancer prevention (38) . 
DEN model is effective to identify novel biomarkers for early diagnosis of human HCC (30) . Indeed, inhibition of AA metabolic pathway has been recently reported to associate with the chemoprevention of high fat diet-enhanced colorectal carcinogenesis (41) and the apoptosis of HCC cells (42) . Furthermore, significantly elevated content of AA was also reported in HCC patients compared to the healthy controls (11).
AA is known as a pro-inflammatory precursor playing etiologic roles in multiple cancers (43) . It is possible that through inhibition of AA-regulated signaling pathways ACR might prevent DEN-induced chronic liver inflammation, which finally contributes to hepatic tumorigenesis. This is reasonable as we previously showed enhanced inflammatory response and inhibited serum levels of TNF-α and expression levels of TNF-α, IL-6, and IL-1b mRNA in the liver of db/db mice treated with ACR compared with that treated with DEN alone (20) . Furthermore, in a platelet-derived growth factor overexpressed mouse model, genome-wide expression profile analysis revealed that the repressive effect of ACR on the development of hepatic fibrosis and tumors was related with inflammatory signaling pathways such as "MIF signaling" and "IL-6 signaling" (44) . (Fig. 5 and 6 ). Deletion of NR2F2 led to embryonic lethality with defects in angiogenesis and heart development, suggesting an essential role of NR2F2 in embryogenesis and organization (45) . It was known that aggressive tumor cells shared many characteristics with embryonic progenitors. The discovery of cancer stem cells further increased the interest in the interactions between cancer progression and embryological development (46) . Indeed, biological function of NR2F2 has been proven in prostate carcinogenesis (47) , suggesting NR2F2 as a potential drug target for preventing tumor progression. 
